Sensient Technologies Corp (SXT)

neg -0.43
Today's Range: 65.61 - 66.56 | SXT Avg Daily Volume: 193,500
Last Update: 10/13/15 - 4:04 PM EDT
Volume: 161,010
YTD Performance: 9.65%
Open: $65.78
Previous Close: $66.16
52 Week Range: $49.72 - $70.53
Oustanding Shares: 45,829,475
Market Cap: 3,019,245,813
6-Month Chart
TheStreet Ratings Grade for SXT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.50 1.50 1.50 1.50
Latest Dividend: 0.27
Latest Dividend Yield: 1.64%
Dividend Ex-Date: 08/05/15
Price Earnings Ratio: 28.77
Price Earnings Comparisons:
SXT Sector Avg. S&P 500
28.77 29.30 25.41
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-2.68% 31.82% 82.11%
Revenue -1.30 0.01 0.00
Net Income -35.00 -0.32 -0.12
EPS -33.90 -0.37 -0.14
Earnings for SXT:
Revenue 1.45B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.77 $0.71 $3.04 $3.55
Number of Analysts 3 3 4 4
High Estimate $0.78 $0.73 $3.05 $3.63
Low Estimate $0.75 $0.69 $3.03 $3.50
Prior Year $0.78 $0.71 $3.02 $3.04
Growth Rate (Year over Year) -1.71% 0.47% 0.75% 16.76%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Reports to watch: Retail sales, Beige Book, housing starts.
Jan 09, 2014 | 8:10 AM EST
SXT was upgraded from Hold to Buy, Keybanc said. $56 price target. Company's new leadership should improve returns. 
The list expands to 28 with a new emphasis on financial services.

The Sweet Smell of Upside Real Money Pro($)

International Flavors and Fragrances is doing well in emerging markets -- just wait for a pullback.
Small-caps that raise their dividends year after year signify company health and confident management.

Columnist Conversations

Would certainly be taking notes on Hillary's comments regarding drug companies ahead of tomorrow's session...
The Biotech iShares (IBB) dropped sharply last month and then began consolidating in triangle pattern. The dro...
You have to be positioned to be lucky. Well done, Bob.
Sometimes it's better to be lucky than good! As mentioned below, we added the SNDK nov 62.5 calls today on so...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.